Novo Holdings A/S sold MGX
February 13, 2024 · Form 4 insider transaction
Novo Holdings A/S sold 147,415 shares of Metagenomi Therapeutics, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
147,415
Price
N/A
Total value
N/A
InsiderNovo Holdings A/S
Role10% owner
SecuritySERIES B PREFERRED STOCK
Transaction codeC: Conversion of a derivative
Transaction dateFebruary 13, 2024
Filing dateFebruary 15, 2024
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share of Series B Preferred Stock and Series B-1 Preferred Stock converted into Common Stock, on a one-for-one basis, automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. These shares have no expiration date.